VENARUS

Active material: Diosmin, Hesperidin
When ATH: C05CA53
CCF: Venous drug
ICD-10 codes (testimony): I84, I87.2
When CSF: 01.15.01.01
Manufacturer: OP OBOLENSKOE CJSC (Russia)

PHARMACEUTICAL FORM, COMPOSITION AND PACKAGING

Pills, coated orange-pink, lenticular, elongated shape with rounded ends, with Valium; in cross section showed two layers.

Excipients: gelatin, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, talc.

The composition of the shell: polyethylene glycol 6000, magnesium stearate, hydroxypropyl, sodium lauryl, Titanium dioxide, iron oxide red, iron oxide yellow.

10 PC. – packings Valium planimetric (2) – packs cardboard.
10 PC. – packings Valium planimetric (3) – packs cardboard.
15 PC. – packings Valium planimetric (2) – packs cardboard.
15 PC. – packings Valium planimetric (3) – packs cardboard.

Pharmacological action

Venous drug. Provides and angioprotectornoe venotonizirutee action.

Decreases vein distensibility, and increases their tone and reduces venous stagnation. Reduces the permeability, fragility of capillaries and increases their resistance. Improves microcirculation and lymph flow.

The methodical implementation reduces the severity of clinical manifestations of chronic venous insufficiency of the lower extremities of organic and functional nature.

Pharmacokinetics

T_1/2 the drug is 11 no. Return with urine and faeces.

Testimony

— venous insufficiency of lower extremities functional and organic nature (feeling of heaviness in the legs, pain, convulsions, trophic disorders);

-acute and chronic hemorrhoids.

Dosage regimen

The drug is taken orally.

At venous insufficiency by 1-2 tab. / day (at noon and in the evening during mealtimes).

At acute hemorrhoids by 6 tablets/day for the first 4 days, then 4 tab. / day for 3 days.

Side effect

Other: dyspepsia, vegetative lability.

Contraindications

- Lactation;

- Hypersensitivity to the drug.

Pregnancy and lactation

The drugs in pregnancy, Since the experiments did not show teratogenic effects, and so far there were no reports of any adverse events in the application of the drug in pregnant patients.

Use is contraindicated in lactation, because there are no data about the allocation of the drug in breast milk.

Cautions

During exacerbation of hemorrhoids use of this drug does not replace specific treatment other anal disorders.

Treatment should not be long. If short therapy is ineffective, should conduct a study and to review the applicable proctology therapy.

Overdose

Data on overdose are not provided.

Drug Interactions

The medication with drug not available.

Conditions of supply of pharmacies

The drug is released under the prescription.

Conditions and terms

List B. The drug should be stored out of reach of children, dry, dark place at a temperature no higher than 25 ° C. Shelf life – 2 year.